Abstract
Effect of the Diabetic Environment On the Expression of MiRNAs in Endothelial Cells

Introduction
Diabetes, which is caused by sustained over-nutrition and disturbed insulin secretion and sensitivity, has become the third major disease that threatens human health, following cancer and cardiovascular disease [1] .Vascular complications are very common in type 2 diabetes mellitus (T2DM), and 50% of newly diagnosed T2DM patients also have vascular diseases [2] [3] .
Recently, many studies have noted that the vascular endothelial cell (VEC) dysfunction is the initiating factor in vascular diseases, and protecting VECs from injury is very important for preventing vascular complications in patients with diabetes mellitus (DM). Moreover, damage to the VECs can cause a series of pathological changes that are crucial for the development of diabetic vascular disease and systemic vascular disease [4] [5] . Therefore, more attention should be paid to VEC injuries because vascular disease directly affects the prognosis and survival of patients with DM.
VECs, which have a highly developed endoplasmic reticulum (ER), are very sensitive to endoplasmic reticulum stress (ERS). The effects of the intracellular glucose concentration on the ER are substantial. High concentrations of glucose can activate endothelial cells [6] , but long-term hyperglycemia leads to sustained and non-remitting ERS. An appropriate level of ERS is beneficial for maintaining the stability of the cell, while long-term ERS can lead to cell apoptosis and the development of many diseases [7] . There have been many reports regarding ERS in endothelial cells; ERS may be an important factor in vascular endothelial injury in T2DM [8] [9] [10] and is considered an increasingly important factor for the genesis and development of atherosclerosis and cardiovascular complications. miRNAs are non-coding endogenous RNAs (22-25 nucleotides in length) that regulate gene expression by binding to complementary sequences in the 3' UTRs of target mRNAs. miRNAs can exert protective or damaging effects on cell proliferation, differentiation, apoptosis, individual development and disease pathology by regulating target genes. Currently, there are many reports regarding the relationship between miRNAs, DM and cardiovascular disease [11] [12] [13] [14] [15] . However, there are few reports regarding the miRNA regulation of ERS-associated signaling pathways that improve endothelial dysfunction and diabetic vascular complications.
In our previous studies, we demonstrated that miR-1283 was involved in the pathogenesis and maintenance of hypertension by regulating the endoplasmic reticulum stress pathway [16] [17] [18] . In this study, we found a microRNA that regulates ERS makers in a diabetic environment. We hypothesize that miR-149-5p and TNF-α play key roles in the pathogenic processes of vascular injury in T2DM. The over-expression of miR-149-5p may exert protective effects on high glucose-induced injury in HUVECs by restoring the ameliorated high glucose-induced expression of the ER stress (ERS) markers.
Materials and Methods
Reagents
The HUVECs were purchased from ATCC ® (CRL-1730, USA). Dulbecco's Modified Eagle's Medium (DMEM), fetal bovine serum (FBS) and phosphate balanced solution (PBS) were purchased from Gibco (Gib- and were dissolved in DMEM with 10% FBS. The miR-149-5p mimic, miR-149-5p inhibitor, si-TNF-α and their negative controls were purchased from Guangzhou RiboBio Co., Ltd. (Guangzhou, China). A pmir-GLO Dual-Luciferase miRNA Target Expression Vector and the Griess Reagent System were purchased from Promega (Promega, Madison, CA, USA). The quantitative real-time polymerase chain reaction (qRT-PCR) reagents were purchased from TaKaRa (TaKaRa, Japan). The TNF-α, GRP78, CHOP, Bcl-2, BAX, eNOS and GAPDH primers were synthesized by the Shanghai Generay Biotech Co., Ltd. (Guangzhou, China). The ET-1, vWF and ICAM-1 ELISA kits were purchased from Cusabio Biotech Co., Ltd. (Wuhan, China). The PERK, elF2α, p-elF2α, GRP78, CHOP, Bcl-2, BAX, eNOS and GAPDH monoclonal antibodies were purchased from the CST Biotechnology Company (Cell Signaling Technology, Boston, MA, USA). An Annexin V/PI apoptosis detection kit was purchased from KeyGene Biotech (Nanjing, China).
Grouping and serum collection
Patients with T2DM who were treated at the Huaqiao Hospital Affiliated with Jinan University between September 2011 and October 2012 and healthy volunteers from Jinan University Medical School were included in this study ( Table 1) . The serum was obtained from the fasting blood of the diabetic patients (fasting plasma glucose (FPG):7.95±0.84 mmol/L) and healthy volunteers (fasting plasma glucose (FPG):4.3±0.62 mmol/L). In addition, the diabetic patients were newly diagnosed and untreated. Both groups were instructed to not consume drugs prior to the blood collection. All samples were obtained from the forearms and collected in dry, sterile vacuum tubes without an anti-coagulation coating. After coagulation, the samples from the two groups were centrifuged at 4, 000 r/min for 15 min at 4 °C and then incubated in a water bath at 56 °C for 30 min to inactivate the serum complement. Finally, the samples were stored at -20 °C.
Establishing a model of vascular injury in HUVECs for sequencing
The HUVECs were cultured in DMEM with 10% FBS at 37 °C in a 5% CO 2 incubator. When the cells reached 40-50% confluency, DMEM was replaced with an F12K medium, which contained 10% serum from the two groups in five parallel samples. The cells were collected after 24 h. Total RNA was extracted using TRIzol and stored at -20 °C until sequencing.
cDNA library construction and Illumina deep sequencing of mRNAs Total RNA was extracted using TRIzol. The samples for the transcriptome analysis were prepared using an Illumina kit (San Diego, CA, USA) according to the manufacturer's instructions. The total mRNA was purified and cleaved into fragments. Then, the cDNA fragments were purified, resolved and ligated with the sequencing adapters before the PCR amplification to create the final cDNA library. The mRNA transcriptome sequencing was performed using second-generation Illumina Solexa sequencing technology. An Illumina TruSeq TM RNA Sample Prep kit was used to sequence the cDNA library (300 bp), and the chromatogram data from the sequencing were transformed into millions of nucleotide sequences with Base Calling. The sequences were stored in a FASTQ format file to call the reads. To conduct further analyses, the raw sequence reads were processed into clean reads by eliminating the low-quality sequences using quality control protocols on the raw sequencing data.
The high-quality sequences obtained using the quality control protocols were compared with the specified reference genome according to the mapping rate. The clean reads were mapped to a transcriptome reference database using TopHat (http://tophat.cbcb.umd.edu/) and Bowtie (TopHat's built-in software). We compared the sample and the reference genomes using Cuffdif software (http://cufflinks.cbcb.umd. 
SE library construction and Illumina deep sequencing of miRNAs
The original image data obtained by the Illumina sequencing were transformed into sequence data by Base Calling and stored in a FASTQ format file with the called reads. The FASTQ format can record the base and mass fraction of the detected reads. To ensure the accuracy of the subsequent bioinformatics analysis, the raw reads were processed into clean reads using quality control protocols. Finally, we retained only data from sequences with a length of 18-32 bp. SeqPrep (https://github.com/jstjohn/SeqPrep),Sickle (https:// github.com/najoshi/sickle), and Fastx-Toolkit (http://hannonlab. Cshl. edu /fastx_toolkit/) were used in the quality control process. Sequences of the same reads were combined to obtain the unique sequence, which was used to analyze the species and abundance of small RNAs in the statistical sample. The annotation of the measured small RNA was accomplished using Rfam (11.0, http://Rfam.sanger.ac.uk/). After removing the non-miRNA sequences (rRNA, scRNA, snoRNA, snRNA, and tRNA), we located the small RNA sequences in the reference genome and analyzed the distribution of these sequences in the genome. The analysis of the differences between the samples was conducted using DEGseq (http://www.bioconductor.org/packages / release /bioc/html/DE Gseq.html). The relative changes in the FPKM values were compared among the different samples, and comparisons with a fold change (FC) > 2 or P-value < 0.01 (fisher's exact test) were considered significantly differentially expressed miRNAs.
Analysis of differentially expressed mRNAs and miRNAs
The transcript abundance reflects the level of gene expression, and the higher the transcript abundance, the higher the level of the gene expression. In the RNA-seq analysis, the gene expression level was estimated by the number of clean reads that were located in the genomic region. Then, we identified the differentially expressed genes by calculating the FPKM value of each gene according to the results of the comparisons of all samples and the human reference genome.
RNAhybrid (http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/) and miRanda (http://www. microrna.org/microrna/home.do) were used to predict the target genes of the miRNAs, and we used these findings to cross-reference the differentially expressed miRNAs and mRNAs.
A GO analysis was used to determine the functional annotations of the potential candidate genes in the T2DM group using GOatools (https://github.com/tanghaibao/GOatools). The differences in the expression of significantly enriched genes in the Kyoto Encyclopedia of Genes and Genomes (KEGG) database were used to identify cellular pathways. Additionally, we used KOBAS (http://kobas.cbi.pku.edu.cn/home.do) in KEGG to perform this analysis.
Network construction of the differentially expressed miRNAs and genes
The target gene prediction software RNAhybrid and miRanda were used to predict the target genes of the differentially expressed miRNAs. We associated all differentially expressed miRNAs and genes using the target gene prediction software and eliminated all genes that were positively correlated with miRNA expression and that negatively regulated the expression of their target genes.
Targeting the relationship between miR-149-5p and TNF-α
Primers targeting the sequences of TNF-α, the TNF-α 3' UTR and miR-149-5p were designed using the NCBI database, and the products were used to obtain the 3' UTR of the target gene. Luciferase activities were measured 48 h after the transfection using the Dual-Luciferase Reporter System.
Cell culture and transfection
HUVECs were cultured in DMEM containing 10% fetal calf serum (FBS). The high glucose group was treated with 30 mM D-glucose. The normal control group was treated with 5.5 mM D-glucose. The isotonic group was treated with 5.5 mM D-glucose and 24.5 mM mannitol. After the HUVECs reached 70-80% confluency, the cells were transfected in 6-well plates (5×10 5 cells per well).
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The miR-149-5p mimic (50 mM), si-TNF-α (50 mM) and their negative control (50 mM) were transfected into the high glucose-treated HUVECs at a D-glucose concentration of 30 mM. The miR-149-5p inhibitor (100 mM) and its negative control (100 mM) were transfected into conventionally cultured HUVECs at a D-glucose concentration of 5.5 mM. The transfection of all groups was performed using Lipofectamine TM 2000 according to the liposome method. After 6 h, the medium was replaced, and the cells were incubated for 48 h and then collected.
Detection of NO, ET-1, vWF and ICAM-1
Forty-eight hours after the transfection, the supernatant was collected, and the OD values of NO, ET-1, ICAM-1 and vWF in the supernatant were detected using microplate reader. The relative content of NO in the cells was detected using the Griess Reagent System. The contents of ET-1, vWF and ICAM-1 were detected using ELISA kits. Then, the expression levels of NO, ET-1, vWF and ICAM-1 were calculated using formulas.
Determination of the mRNA and miRNA expression by qRT-PCR
Total RNA was extracted from each group. PCR was performed according to the manufacturer's instructions, and the classic 2 -ΔΔCT method was used to determine the expression levels. The gene primers were designed based on the sequences in the NCBI gene database. The miR-149-5p primers were designed by Guangzhou RiboBIO, Co., Ltd. (Guangzhou, China).
Protein detection
Proteins were extracted and separated on 8% SDS-PAGE or 12% SDS-PAGE and then transferred onto a PVDF membrane. Subsequently, the membrane was washed, sealed and incubated with a monoclonal antibody (1:1000) at 4 °C overnight. Then, horseradish peroxidase IgG (1:12000) was added, and the membrane was incubated at 37 °C for 1 h. After washing with TBST, diaminobenzidine was added for color development. We determined the quantitative values based on the absorbance of each band using ImageJ software.
Detection of cell apoptosis
Apoptosis in the HUVECs was determined by flow cytometry using the Annexin V/PI apoptosis detection kit according to the manufacturer's instructions. Briefly, HUVECs were digested with trypsin (without EDTA) and suspended in 500 μl of binding buffer at a density of 1×10 6 /mL. Then, 5 µl of Annexin V and 5 µl of PI were added to the suspension, which was then vortexed and incubated for 20 min in the dark at room temperature. Finally, the cells were analyzed using flow cytometry. Apoptosis was evaluated by calculating the ratio of the percentage of apoptotic cells to total cells.
Statistical analysis
All experiments were repeated at least three times. The data were analyzed using one-way ANOVA, and the data are presented as the mean ± standard error of the mean. P < 0.05 was considered statistically significant.
Results
Overview of the transcriptome sequencing and small RNA sequencing Illumina sequencing technology and digital gene expression (DGE) were used to sequence two HUVEC samples that were incubated in serum from diabetic patients and healthy volunteers. In total, 4, 718, 7011 raw reads were (Table 2) . We obtained the clean reads from the small RNA sequencing after performing quality control protocols (Table 3) . Then, we combined the same reads and obtained the unique sequence, which was used to analyze the species and abundance of small RNAs. Furthermore, the types and distribution of the common small RNA sequences in the two samples and their respective small RNA sequences were analyzed (Fig. 1A) . Finally, the small RNA sequences were located in the reference genome to analyze the distribution of these sequence in the genome (Fig. 1B) .
Differentially expressed mRNAs and miRNAs
Using transcriptome sequencing and small sequencing in the two groups, we obtained the differentially expressed mRNAs and miRNAs after performing quality control protocols and data filtering of the raw reads. A total of 234 mRNAs were differentially expressed (94 upregulated and 140 downregulated) in the five parallel samples from the T2DM group compared with the normal control group. Similarly, 447 miRNAs were also differentially expressed (190 upregulated and 257 downregulated) according to the statistics (Fig. 1C) .
The target gene prediction software were used to predict the target genes of the differentially expressed miRNAs. By combining the transcriptome sequencing analysis and the target gene prediction, we obtained the duplicate genes and their corresponding 
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Cellular Physiology and Biochemistry miRNAs. In total, 421 mRNA/ miRNA pairs were selected after cross-referencing the target genes to the differentially expressed mRNAs in the transcriptome sequencing analysis. Then, 42 pairs were retained by retaining the negatively associated mRNA/ miRNA pairs and removing the positive mRNA/miRNA pairs (Table 4) . Finally, Cytoscape (http://www.cytoscape.org/) was used in the miRNA-mRNA interaction network analysis (Fig.  3) .
Gene Ontology (GO) analysis and pathway enrichment analysis
The GO terms are divided into the following three categories: biological process (BP), molecular function (MF) and cellular component (CC). Fig. 2 shows the GO functional classifications of the differentially expressed genes. The regulation of developmental process (40 background genes and 4 differentially expressed genes) and the regulation of transcription from the RNA polymerase II promoter (109 background genes and 5 differentially expressed genes) were specifically enriched terms in BP. The enriched terms in MF and CC were unclassified.
KEGG was used to identify the cellular pathways. The pathway enrichment analysis of the differentially expressed genes showed that most genes were related to a pathway that is associated with nervous system disease, tumor development and oxidative phosphorylation (Table  5) .
TNF-α and miR-149-5p are differentially expressed in Illumina sequencing and negatively correlated in high glucose-treated HUVECs
The log2 ratios were determined by comparing the expression of the 42 pairs of differentially expressed miRNA/miRNA. We found significant differences in TNF-α and miR-149-5p between the T2DM group and the healthy controls (Fig. 4A) . Furthermore, the software predicted that TNF-α is the target gene of miR-149-5p. Total RNA was extracted from HUVECs that were treated with different concentrations of D-glucose (5.5 mmol/L, 10 mmol/L, 20 mmol/L, and 30 mmol/L) at different times (3, 5, and 7 days). The 2 -ΔΔCT method was used to determine the expression level of miR-149-5p and TNF-α. The results showed that the expression of TNF-α was positively correlated with the concentration of D-glucose (Fig. 4B) , while miR-149-5p was negatively associated with the concentration of D-glucose (Fig. 4C) . According to the sequencing analysis and multiple significant differences, miR-149-5p and TNF-α were selected for the next study. 
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TNF-α is a direct target of miR-149-5p in HUVECs
The Dual-Luciferase Reporter Assay System was used to assess the relationship between TNF-α and miR-149-5p. Wild-type and mutant TNF-α were separately inserted at the 3' end of the firefly luciferase gene (Fig. 4D) . Then, the miR-149-5p mimic was co-transfected with a no-insert control or a TNF-α wild-type or mutant luciferase reporter into the HUVECs. Compared to the no-insert controls (NC), the firefly luciferase activity of the wild-type TNF-α luciferase reporter (TNF-α-WT) was decreased to 70%, but the activity of the mutant TNF-α luciferase reporter (TNF-α-Mut) was relatively unchanged at 93.6% (Fig. 4E) . These results showed that miR-149-5p significantly decreased the firefly luciferase activity of the wildtype TNF-α reporter.
miR-149-5p and TNF-α affect the expression of ER stress markers in vascular endothelial cells
Compared to the high glucose group, the miR-149-5p mimic group and the si-TNF-α group exhibited decreased mRNA levels of TNF-α, GRP78, PERK, CHOP and BAX and increased mRNA levels of Bcl-2. In contrast, the mRNA levels of TNF-α, GRP78, PERK, CHOP and BAX were significantly increased, and the mRNA levels of Bcl-2 were decreased in the miR-149-5p inhibitor group compared to the normal control group (Fig. 5) .
Compared to the high glucose group and the negative control groups, the miR-149-5p mimic group and the si-TNF-α group exhibited decreased protein levels of PERK, elF2α, p-elF2α, GRP78, CHOP and BAX and increased protein levels of Bcl-2 (P<0.05). The protein levels of PERK, elF2α, p-elF2α, GRP78, CHOP and BAX were significantly increased, and the protein levels of Bcl-2 were decreased in the miR-149-5p inhibitor group compared to the normal control group (Fig. 6) . 
miR-149-5p and TNF-α affect vascular endothelial cell injury
The culture medium was collected after 48 h, and the expression of NO, ET-1, vWF and ICAM-1 was calculated according to their respective formulas. The relative content of NO in the cells was detected using the Griess Reagent System. The content of ET-1, vWF and ICAM-1 was detected using ELISA kits. Compared to the high glucose group and the negative control group, the miR-149-5p mimic group and the si-TNF-α group showed significantly increased NO levels, and the levels of ET-1, vWF, and ICAM-1 were significantly decreased (P<0.05). In contrast, the level of NO was decreased in the miR-149-5p inhibitor group, and the levels of ET-1, vWF, TM, and ICAM-1 were increased (Fig. 7.A-D) . Compared to the high glucose group, the miR-149-5p mimic group and the si-TNF-α group exhibited an increased mRNA level (Fig. 7F ) and protein level of eNOS (Fig. 7G-H) .
Apoptosis was determined by flow cytometry using the Annexin V/PI apoptosis detection kit. After the treatments, the samples were stained with Annexin V and PI and quantitatively analyzed at 488 nm emission and 570 nm excitation using a flow cytometer following the manufacturer's protocols. Compared with the normal control group, the high glucose group and the miR-149-5p inhibitor group exhibited significant increases in HUVEC apoptosis. In contrast, compared to the high glucose group, the miR-149-5p mimic group and the si-TNF-α group showed significant reductions in cell apoptosis (Fig. 7E) . However, reports regarding the mechanism of VEC injury are scarce. Therefore, in this study, we sought to identify miRNAs that could serve as markers of endothelial dysfunction during the early stages of diabetes and its complications. Improving early vascular endothelial damage in diabetes, which can reduce the long-term damage to the blood vessels caused by hyperglycemia, is very important. In our study, an early diabetic endothelial cell model was constructed using patient serum interventions. These serum constituents were complex. In addition, diabetic subjects are characterized by an altered circulating miRNA profile [25] , metabolic profile and certain other profiles. A diabetic VEC model was established using this method.
We choose typical diabetic subjects at different ages (65±8.4) and young healthy controls (27±3). To study the mechanism of endothelial cell injury in diabetic patients, a HUVEC model was established using serum from diabetic patients. Then, the differential expression of the mRNAs and miRNAs in the cell model were screened by Illumina sequencing. In total, 447 miRNAs and 234 mRNA were related to T2DM. These miRNAs and mRNAs were mainly concentrated in neurodegenerative diseases and cancer, such as Parkinson's disease, Alzheimer's disease, and pathways in cancer, according to the GO and KEGG analyses. Thus, vascular injury caused by diabetes is closely related to these two types of diseases.
Furthermore, in these differentially expressed factors, miRNA-149-5p is lowly expressed, and TNF-α is highly expressed in damaged VECs compared with their expression levels in normal subjects. The miRNA-Target mRNA software prediction and the dualluciferase reporter assays indicated that TNF-α was a target gene of miR-149-5p. This finding suggested that miRNA-149-5p plays an important role in endothelial dysfunction in the diabetic environment by negatively regulating the expression of TNF-α. Furthermore, we showed that miR-149-5p inhibited the release of inflammatory factors and improved the endothelial dysfunction caused by inflammation. The over-expression of miR-149-5p could increase the level of NO (an in vivo signaling molecule and a protective factor in VECs [26] [27] [28] ) and eNOS (endothelial nitric oxide synthase. In endothelial cells, NO is mainly produced by eNOS [29] [30] ) and decrease the levels of ET-1 (which damages VECs by strongly contracting vascular smooth muscles [31] [32] [33] ), vWF (a marker of vascular injury or vascular functional disturbances [34] [35] [36] ) and ICAM-1 (a marker of inflammation in endothelial cells [37] [38] ) in HG-treated HUVECs. Recent studies have also shown that miR-149 not only participates in the anticancer mechanism [39] [40] [41] [42] but also acts as an important new regulator of endothelial function [43] . In addition, TNF-α was importance in tumorigenesis [44] [45] and the initiation and progression of vascular disorders by modulating the expression of molecules that are involved in vascular tone, inflammation and remodeling, thus inducing endothelial inflammation and dysfunction [46] [47] [48] [49] .
Diabetes research has demonstrated an association between TNF-α [50] [51] and ESR [52] . Apoptosis of VECs is merely the initial stage of cardiovascular disease, and the ERS signaling pathway plays an important role in the regulation of VEC dysfunction [53] . The misfolded protein response-induced apoptosis and inflammation are linked to the pathogenesis of VEC damage [54] . In this study, we also found that the low expression of TNF-α or overexpression of miR-149-5p could affect the expression of certain ERS markers in high glucosetreated endothelial cells. The expression of the ERS marker GRP78 and the upstream genes PERK, eIF2α and p-eIF2α were inhibited in the HG-treated HUVECs. Additionally, the overexpression of miR-149-5p or the under-expression of TNF-α affected the expression of the pro-apoptotic genes CHOP and BAX and the anti-apoptotic gene Bcl-2. These results suggested that miR-149-5p and its target gene TNF-α could inhibit inflammation, affect the expression of the ERS markers and inhibit the ERS-associated apoptosis in HG-treated VECs.
Conclusion
The miRNA profile was an important factor in vascular injury in endothelial cells in a diabetic environment. The present study suggests that miR-149-5p protects against Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry
